DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Sinnberg T, Lasithiotakis K, Niessner H.
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to Cisplatin and Temozolomide.
J Invest Dermatol 2009;
129: 1500-1515
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.